SERPINF2 and obesity disorder: To investigate the potential therapeutic effect of Api on obesity and its associated complications, we fed mice with a HFD for 16 weeks (Figure 1A) and observed that the body weight and body weight gain were markedly elevated compared with the ND feeding (Figures 1B,C).